Filing Details

Accession Number:
0000921895-25-000547
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2025-02-19 20:04:57
Reporting Period:
2025-02-12
Filing Date:
2025-02-19
Accepted Time:
2025-02-19 20:04:57
Original Submission Date:
2025-02-14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1565228 Vislink Technologies Inc. VISL () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1272935 Jr M Martin Hale 17 State Street, Suite 4000
New York NY 10004
No No Yes No
1458726 Hale Capital Partners, Lp 17 State Street, Suite 4000
New York NY 10004
No No Yes No
1458727 Hale Fund Partners, Llc 17 State Street
Suite 4000
New York NY 10022
No No Yes No
2057027 Hale Capital Management, Lp 17 State Street
Suite 4000
New York NY 10004
No No Yes No
2057028 Hale Fund Management, Llc 17 State Street
Suite 4000
New York NY 10004
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Par Value $0.00001 Per Share Acquisiton 2025-02-12 20,000 $2.45 295,415 No 4 P Indirect See footnote
Common Stock Par Value $0.00001 Per Share Acquisiton 2025-02-13 845 $2.52 296,260 No 4 P Indirect See footnote
Common Stock Par Value $0.00001 Per Share Acquisiton 2025-02-14 8,148 $2.48 304,408 No 5 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 5 P Indirect See footnote
Footnotes
  1. The shares of Common Stock par value $0.00001 per share (the "Shares") of Vislink Technologies, Inc. are directly beneficially owned by Hale Capital Partners, LP ("HCP"). As the CEO of HCP and managing member of Hale Fund Partners, LLC ("HFP"), Martin M. Hale, Jr. may be deemed to beneficially own the shares. As the general partner of Hale Capital Management, LP ("HCM"), the investment manager of HCP, Hale Fund Management, LLC ("HFM") may be deemed to beneficially own the Shares. As the general partner of HCP, Hale Fund Partners, LLC may be deemed to beneficially own the Shares.